These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17850927)

  • 21. Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
    Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Kornhuber J; Frölich L; Heuser I; Peters O; Schulz JB; Schwab SG; Maier W
    Neurosci Lett; 2008 Jul; 440(1):68-71. PubMed ID: 18541377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis.
    Qiu XS; Tang NL; Yeung HY; Lee KM; Hung VW; Ng BK; Ma SL; Kwok RH; Qin L; Qiu Y; Cheng JC
    Spine (Phila Pa 1976); 2007 Jul; 32(16):1748-53. PubMed ID: 17632395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
    Blain JF; Aumont N; Théroux L; Dea D; Poirier J
    Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in the APP gene promoter region and risk of Alzheimer disease.
    Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
    Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S; Väkevä A; Hiltunen M; Soininen H
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease.
    Brune S; Kölsch H; Ptok U; Majores M; Schulz A; Schlosser R; Rao ML; Maier W; Heun R
    J Neural Transm (Vienna); 2003 Sep; 110(9):1041-50. PubMed ID: 12938026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease.
    Liu HP; Lin WY; Liu SH; Wang WF; Tsai CH; Wu BT; Wang CK; Tsai FJ
    Dement Geriatr Cogn Disord; 2009; 28(6):521-7. PubMed ID: 20016182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a NOS1 promoter repeat with Alzheimer's disease.
    Galimberti D; Scarpini E; Venturelli E; Strobel A; Herterich S; Fenoglio C; Guidi I; Scalabrini D; Cortini F; Bresolin N; Lesch KP; Reif A
    Neurobiol Aging; 2008 Sep; 29(9):1359-65. PubMed ID: 17418914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
    Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
    Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
    Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
    Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
    Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
    Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients.
    Wu YH; Fischer DF; Swaab DF
    Brain Res; 2007 Sep; 1167():13-9. PubMed ID: 17692293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
    Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
    Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
    Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
    Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
    Leduc V; Théroux L; Dea D; Robitaille Y; Poirier J
    Eur J Neurosci; 2009 Nov; 30(9):1823-30. PubMed ID: 19863653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population.
    Ito Y; Nakamura Y; Takahashi N; Saito S; Aleksic B; Iwata N; Inada T; Ozaki N
    Neurosci Lett; 2008 Jun; 438(1):70-5. PubMed ID: 18455306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
    J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.